Trials / Conditions / ESR1 Gene Mutation
ESR1 Gene Mutation
6 registered clinical trials studyying ESR1 Gene Mutation — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) NCT07222215 | Kristina A. Fanucci | Phase 2 |
| Recruiting | Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. NCT06382948 | MedSIR | Phase 3 |
| Recruiting | Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer NCT06548919 | SciClone Pharmaceuticals | — |
| Recruiting | Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC NCT06544577 | SciClone Pharmaceuticals | — |
| Recruiting | FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer NCT04174352 | University of Wisconsin, Madison | EARLY_Phase 1 |
| Unknown | Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulatin NCT05814224 | Centro di Riferimento Oncologico - Aviano | N/A |